The roles of YAP T425A mutation in the regulation of YAP activity
Received date: 2017-02-28
Revised date: 2017-04-18
Online published: 2017-07-04
Supported by
the National Natural Science Foundation of China(81402319);Beijing Novel Project(Z161100004916133)
The Hippo signaling pathway plays a critical role in body development and tissue growth. As the core effector of the Hippo signaling pathway, Yes-associated protein (YAP) has been reported to be involved in various kinds of human cancers. However, the mechanism for the regulation of YAP activity has not been completely understood. In this study, we constructed a YAP Thr425Ala mutant and found that this mutation decreased YAP transcriptional activity. Further, T425A retained YAP in the cytoplasm without affecting the phosphorylation of YAP S127. Moreover, we observed that the T425A mutation attenuated the ability of YAP in driving MCF10A cell migration. Our research indicates that T425 of YAP is important for the regulation of YAP localization and activity.
lu Yang, Zhuangzhi Zou, , Beibei Mao, . The roles of YAP T425A mutation in the regulation of YAP activity[J]. Hereditas(Beijing), 2017 , 39(7) : 675 -682 . DOI: 10.16288/j.yczz.17-068
| [1] | Harvey KF, Pfleger CM, Hariharan IK. The Drosophila mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell, 2003, 114(4): 457-467. | |||
| [2] | Piccolo S, Dupont S, Cordenonsi M. The biology of YAP/TAZ: hippo signaling and beyond. Physiol Rev, 2014, 94(4): 1287-1312. | |||
| [3] | Hansen CG, Moroishi T, Guan KL. YAP and TAZ: a nexus for Hippo signaling and beyond. Trends Cell Biol, 2015, 25(9): 499-513. | |||
| [4] | Harvey K, Tapon N. The Salvador-Warts-Hippo pathway- an emerging tumour-suppressor network. Nat Rev Cancer, 2007, 7(3): 182-191. | |||
| [5] | Meng ZP, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev, 2016, 30(1): 1-17. | |||
| [6] | Huang JB, Wu SA, Barrera J, Matthews K, Pan DJ. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell, 2005, 122(3): 421-434. | |||
| [7] | Zanconato F, Cordenonsi M, Piccolo S. YAP/TAZ at the roots of cancer. Cancer Cell, 2016, 29(6): 783-803. | |||
| [8] | Zeng Q, Hong WJ. The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer Cell, 2008, 13(3): 188-192. | |||
| [9] | Zhao B, Wei XM, Li WQ, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu JD, Li L, Zheng P, Ye KQ, Chinnaiyan A, Halder G, Lai ZC, Guan KL. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev, 2007, 21(21): 2747-2761. | |||
| [10] | Zhang X, George J, Deb S, Degoutin JL, Takano EA, Fox SB, AOCS Study group, Bowtell DDL, Harvey KF. The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene. Oncogene, 2011, 30(25): 2810-2822. | |||
| [11] | Steinhardt AA, Gayyed MF, Klein AP, Dong JX, Maitra A, Pan DJ, Montgomery EA, Anders RA. Expression of Yes-associated protein in common solid tumors. Hum Pathol, 2008, 39(11): 1582-1589. | |||
| [12] | Wang KN, Degerny C, Xu MH, Yang XJ. YAP, TAZ, Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease. Biochem Cell Biol, 2009, 87(1): 77-91. | |||
| [13] | Zhao B, Ye X, Yu JD, Li L, Li WQ, Li SM, Yu JJ, Lin JD, Wang CY, Chinnaiyan AM, Lai ZC, Guan KL. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev, 2008, 22(14): 1962-1971. | |||
| [14] | Chen Q, Zhang NL, Xie R, Wang W, Cai J, Choi KS, David KK, Huang B, Yabuta N, Nojima H, Anders RA, Pan DJ. Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP. Genes Dev, 2015, 29(12): 1285-1297. | |||
| [15] |
/
www.chinagene.cn
版权所有 © 中国科学院遗传与发育生物学研究所 中国遗传学会
地址：北京市朝阳区北辰西路1号院 中国科学院遗传与发育生物学研究所2号楼B-208 邮政编码：100101 联系电话：010-64807669 E-mail：yczz@genetics.ac.cn 
|